Company names starting with "Q"

Patents whose numbers are in italics have been extended under 35 USC 156. Unless otherwise noted, all expiration dates include applicable Sec. 156 and pediatric (PED) extensions.

QOL Medical, LLC
Sucraid (Solution For Oral) (Oral) sacrosidase
Drug Classes: Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
NDA Applicant: QOL Medical, LLC      BLA No.: 020772  Prod. No.: 001 Rx (1,003,000IU/118ML (8,500IU/ML)); 002 Rx (17,000IU/2ML (8,500IU/ML))
ExclusivityExpirationExclusivity Description
Exclusivity Type: Orphan Drug ExclusivityApr 9, 2005Orphan Designation: Treatment of congenital sucrase-isomaltase deficiency
Approved Labeled Indication: Oral replacement therapy of the genetically determined sucrase deficiency, which is part of congenital sucrease-isomaltase deficiency.

Last edited: 15 November 2022
© 2001-2022 Bruce A. Pokras, All rights reserved worldwide